Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
about
A rational approach to single, dual and triple therapy in COPDPrevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline.The association of lung function and St. George's respiratory questionnaire with exacerbations in COPD: a systematic literature review and regression analysisCopd.Global Strategy for the Diagnosis, Management and Prevention of Chronic Obstructive Lung Disease 2017 Report: GOLD Executive Summary.Diagnosis and pharmacotherapy of stable chronic obstructive pulmonary disease: the finnish guidelines.Concurrent oral and inhalation drug delivery using a dual formulation system: the use of oral theophylline carrier with combined inhalable budesonide and terbutaline.Application of a Physiologically Based Pharmacokinetic Model to Study Theophylline Metabolism and Its Interactions With Ciprofloxacin and Caffeine.Respirology year-in-review 2006: clinical science.Update in chronic obstructive pulmonary disease 2006.Guidelines for diagnosis and management of chronic obstructive pulmonary disease: Joint ICS/NCCP (I) recommendations.Exacerbation rate, health status and mortality in COPD--a review of potential interventionsThe Saudi Guidelines for the Diagnosis and Management of COPD.Do we know the minimal clinically important difference (MCID) for COPD exacerbations?Update on the pathological processes, molecular biology, and clinical utility of N-acetylcysteine in chronic obstructive pulmonary disease.Protective effect of aminophylline against cigarette smoke extract-induced apoptosis in human lung fibroblasts (MRC-5 cells).Updates in the management of stable chronic obstructive pulmonary disease.Phosphodiesterase 4 inhibitors for the treatment of chronic obstructive pulmonary disease: a review of current and developing drugs.Prediction and prevention of exacerbations and mortality in patients with COPD.Theophylline is able to partially revert cachexia in tumour-bearing rats.Inhibitory effects of theophylline on the peroxynitrite-augmented release of matrix metalloproteinases by lung fibroblasts.Multidisciplinary COPD disease management program: impact on clinical outcomes.Effectiveness of Bufei Yishen Granule combined with acupoint sticking therapy on quality of life in patients with stable chronic obstructive pulmonary disease.Moving forward: Respirology supplement on chronic airway inflammation research in China.Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary.Efficacy of tiotropium in COPD patients from Asia: a subgroup analysis from the UPLIFT trial.Bronchodilator and Anti-Inflammatory Action of Theophylline in a Model of Ovalbumin-Induced Allergic Inflammation.Effects of YuPingFeng granules on acute exacerbations of COPD: a randomized, placebo-controlled studyPharmacotherapy of Chronic Obstructive Pulmonary Disease: A Clinical Review
P2860
Q26776477-EE46F110-4AC5-453B-B176-8DE982C65874Q27348844-83617DE3-9894-484B-8F18-E250B8462808Q28070325-49D8BA38-4222-4DDF-9F71-D41E5D0949B9Q31016356-2B9ED92F-4965-4583-A97D-A6DA9F71B542Q34550471-BC1E30AE-471D-4A55-9986-07D738B32BF6Q35538249-71C90E0D-533F-4189-88BF-15105092A67AQ35580773-117BA7E6-3266-411A-B388-FD0C84AC799AQ36600064-2941BF83-6018-417E-8B91-D89C09CD643CQ36700939-FE34B0D2-9184-4441-86A9-FEC0AD0B8DCEQ36838782-70D5AFEB-C233-48CF-A529-14174E4C8B6DQ37177278-C0B86EAD-C98D-4A38-822F-B3122A7DAAB4Q37236165-1B7981EE-8B56-4CC2-BB07-DCC1A63CFC1EQ37733309-DE7724A7-C2E4-4A85-9E98-33DA95367634Q38091512-B7E439EF-53EC-4A14-A409-71A9FE48ABDDQ38240136-25C331C0-043A-4FF3-A348-37B0FD529A2DQ38478189-BBD74D85-2431-4D9C-A5D7-8CED10137A8FQ38578596-23824FBC-A229-4C95-BD3B-D5DB9660A223Q38595360-3AE48776-645A-45EE-8B66-4C1D5051EA2DQ38823010-3D5C62AF-AC8F-49BA-98E1-534D6DE6823EQ39293834-7F0AB845-AAD5-4353-8FD9-7E0E459B9E42Q39404591-A3EFC4BD-361B-4C5B-9B48-A23E8306C694Q40238165-6FB17465-95A6-40EF-8214-C08B1A2C7C08Q44014182-EA7DAD61-8254-450F-B6A8-0FAD447981B7Q44591525-4589AF3A-9457-46AF-9A19-FFCC00B69A8CQ47984024-A37DCDFD-256E-46EE-A1C4-02EAA6950FDAQ48679924-24F23B15-21C9-44B8-90CE-C3DBE72CC5E3Q50858805-F5E3293F-0F92-4187-BCFD-C2F2788E5B60Q57483689-94DA62E6-F4B7-491B-B004-CEEA7A86FF39Q58997823-CB12E908-8EB3-4C8E-97A5-54F4A8F198A8
P2860
Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year.
description
2006 nî lūn-bûn
@nan
2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@ast
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@en
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@nl
type
label
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@ast
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@en
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@nl
prefLabel
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@ast
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@en
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@nl
P2093
P2860
P1433
P1476
Positive benefits of theophyll ...... treatment of COPD for 1 year.
@en
P2093
Jingping Zheng
Junfeng Xie
Shengming Liu
Xiangyi Zeng
Xiaoping Wang
Yumin Zhou
P2860
P304
P356
10.1111/J.1440-1843.2006.00897.X
P577
2006-09-01T00:00:00Z